• Explore /
  • Poster
  • / A phase I/II feasibility study of cetuximab with 5FU and mitomycin C or cisplatin with concurrent radiotherapy in muscle invasive bladder cancer.

A phase I/II feasibility study of cetuximab with 5FU and mitomycin C or cisplatin with concurrent radiotherapy in muscle invasive bladder cancer.

Abstract Poster

Authors

Nicholas James

Nicholas D. James

Queen Elizabeth Hospital, Birmingham, United Kingdom

Nicholas D. James , Sarah Pirrie , Wenyu Liu , Daniel Ford , Anjali Zarkar , Elizabeth Southgate , Amisha Desai , Syed A. Hussain

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

80733590

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 491)

Abstract #

491

Poster Bd #

H14

Abstract Disclosures

Similar Posters

First Author: Syed A. Hussain

First Author: Syed A. Hussain

First Author: Christophe Le Tourneau

First Author: Yelena Y. Janjigian